Créer une activité
Jouer Relier
1. Pharmacologic anticoagulant therapy includes the following:
2. Additional therapeutic measures that may be indicated include the following:
3. Current guidelines for patients with moderate- or high-risk ACS include the following:

Factor Xa inhibitors (rivaroxaban, fondaparinux)

Concomitant antithrombotic therapy, including aspirin and clopidogrel, as well as UFH or LMWH

Early invasive approach

Unfractionated heparin (UFH)

Thrombolysis

Low-molecular-weight heparin (LMWH; dalteparin, nadroparin, enoxaparin)

Percutaneous coronary intervention (preferred treatment for ST-elevation MI)